These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6096972)

  • 21. Progress and problems in hemophilia and von Willebrand's disease.
    Abildgaard CF
    Adv Pediatr; 1984; 31():137-77. PubMed ID: 6440429
    [No Abstract]   [Full Text] [Related]  

  • 22. [Diagnosis and therapy of coagulation disorders with special reference to hemophilia].
    Fischer M
    Med Lab (Stuttg); 1982 Oct; 35(4):98-103. PubMed ID: 7155053
    [No Abstract]   [Full Text] [Related]  

  • 23. Transfusion therapy in congenital coagulopathies.
    Lusher JM
    Hematol Oncol Clin North Am; 1994 Dec; 8(6):1167-80. PubMed ID: 7860443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Approaches to plasma fractionation for improved recovery and the development of potentially useful clinical factors.
    Johnson AJ; Mathews RW; Fulton AJ
    Clin Haematol; 1984 Feb; 13(1):3-15. PubMed ID: 6426834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sixteen years of treatment with pasteurized human clotting factor concentrates in children and adolescents: a pharmacosurveillance investigation comprising 727 patient years.
    Muntean W; Zenz W; Falger J; Male C; Streif W; Wank J; Schwarz R; Schmitt K; Kurnik P; Zwiauer K
    Semin Thromb Hemost; 2002 Apr; 28 Suppl 1():63-74. PubMed ID: 12016581
    [No Abstract]   [Full Text] [Related]  

  • 26. [EcoR1 restriction in vivo: possible utilization in genetic engineering].
    Skavronskaia AG; Aleshkin GI; Demkin VV; Strikhanov SN; Evdokimova NM
    Vestn Akad Med Nauk SSSR; 1981; (2):40-6. PubMed ID: 6264708
    [No Abstract]   [Full Text] [Related]  

  • 27. The molecular basis of hemophilia A and the present status of carrier and antenatal diagnosis of the disease.
    Kazazian HH
    Thromb Haemost; 1993 Jul; 70(1):60-2. PubMed ID: 8236115
    [No Abstract]   [Full Text] [Related]  

  • 28. Extracorporeal immunoadsorption for the treatment of coagulation inhibitors.
    Franchini M; Sassi M; Dell'Anna P; Manzato F; Salvagno GL; Montagnana M; Zaffanello M; Targher G; Lippi G
    Semin Thromb Hemost; 2009 Feb; 35(1):76-80. PubMed ID: 19308895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The genetics of blood coagulation.
    Graham JB; Barrow ES; Reisner HM; Edgell CJ
    Adv Hum Genet; 1983; 13():1-81. PubMed ID: 6362359
    [No Abstract]   [Full Text] [Related]  

  • 30. [Molecular genetics and DNA diagnosis for inherited coagulation disorders].
    Tanimoto M; Saito H
    Nihon Rinsho; 1989 Apr; 47(4):864-9. PubMed ID: 2568509
    [No Abstract]   [Full Text] [Related]  

  • 31. [RecA+-independent formation of recombinant plasmids in strains of E. coli producing Eco RI restriction endonuclease].
    Aleshkin GI; Strikhanov SN; Skavronskaia AG
    Dokl Akad Nauk SSSR; 1980; 253(6):1465-9. PubMed ID: 6253252
    [No Abstract]   [Full Text] [Related]  

  • 32. [Production of blood coagulation factors and related factors by gene technology].
    Suzuki K
    Nihon Rinsho; 1987 Dec; 45(12):2971-82. PubMed ID: 2833649
    [No Abstract]   [Full Text] [Related]  

  • 33. Detection of carriers and prenatal diagnosis of bleeding disorders.
    Peake I
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():37-40. PubMed ID: 7886602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant DNA strategies in genetic neurological diseases.
    Roses AD; Pericak-Vance MA; Yamaoka LH; Stubblefield E; Stajich J; Vance JM; Roses MJ; Carter DB
    Muscle Nerve; 1983 Jun; 6(5):339-55. PubMed ID: 6310392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [In vitro construction of recombinant DNA molecules: a new development in genetics (author's transl)].
    De Groot B
    Tijdschr Diergeneeskd; 1976 Dec; 101(24):1364-70. PubMed ID: 1070183
    [No Abstract]   [Full Text] [Related]  

  • 36. Carrier detection of Hemophilia B by using a restriction site polymorphism associated with the coagulation Factor IX gene.
    Grunebaum L; Cazenave JP; Camerino G; Kloepfer C; Mandel JL; Tolstoshev P; Jaye M; De la Salle H; Lecocq JP
    J Clin Invest; 1984 May; 73(5):1491-5. PubMed ID: 6325506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1980 Beaumont Lecture. Restriction enzymes as tools for genetic research.
    Smith HO
    Henry Ford Hosp Med J; 1980; 28(1):5-14. PubMed ID: 6270038
    [No Abstract]   [Full Text] [Related]  

  • 38. [Population and molecular-genetic aspects of hemophilia A and B in Uzbekistan].
    Boboev KT
    Tsitol Genet; 2008; 42(2):51-4. PubMed ID: 18630121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Medical use of molecular cloning].
    Cabello F
    Rev Med Chil; 1984 Jul; 112(7):697-705. PubMed ID: 6083592
    [No Abstract]   [Full Text] [Related]  

  • 40. Recombinant DNA technology and laboratory medicine.
    Rabson AB; Rabson AS
    Arch Pathol Lab Med; 1983 Oct; 107(10):505-9. PubMed ID: 6311140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.